TheSUBWAY.com Posts Stock Watch List: Safer and More Effective!

Market Wire, July, 2004

TheSUBWAY.com names the following stocks to its Stock Watch List! L.A.M. Pharmaceutical (OTC BB: LAMP), BICO Inc. (OTC BB: BIKO), Intel Corporation (NASDAQ: INTC), TiVo Inc. (NASDAQ: TIVO).

LAM Pharmaceutical, Corp. (OTC BB: LAMP) just announced that a successful LAM IPM Wound Gel(TM) pre-launch conference took place in Panama City on June 26th and June 27th. LAM is pleased to announce it has received its first order from the region in excess of $10,000 immediately following the conference, which will be recorded in the Company's third quarter results.

L.A.M. Pharmaceutical, Corp., www.lampharm.com, is a biomedical company with laboratories in Lewiston, New York, and business offices in Toronto, Canada and Beijing, China. LAM focuses on the development and commercialization of novel wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases.

Other stocks highlighted include Intel Corporation (NASDAQ: INTC): Stock Watch List, up 52% on 12 million shares, TiVo Inc. (NASDAQ: TIVO): Stock Watch List, down 40% on 15 million shares, BICO Inc. (OTC BB: BIKO): Stock Watch List, down 1% on 3 million shares.

"Historically speaking, the statistics favor those long on equities. A look at previous market declines reveals that when stocks climb 15 percent or more in the first year of a market rebound, the second year stands a good chance of also putting up positive numbers. What stands at the forefront of investor's worries now, is concerns over rising U.S. interest rates, inflation, and the constant threat of terrorism." More is available at: http://www.thesubway.com/sub_comm.asp.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com/sub_comm.asp.

All material herein was prepared by Capital Research Group, Inc. ("CRG") based upon information supplied by L.A.M. Pharmaceutical Corp. (OTC BB: LAMP) or other sources believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. LAMP has not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. A company's actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market marker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com. LAM Pharmaceutical Corp. -- CRG received from LAMP three million fifty nine thousand three hundred sixty three (3,059,363) shares of common stock of LAMP, one hundred ninety thousand dollars (crg could receive up to one hundred forty thousand additional dollars) and two warrants, one of which entitles CRG to purchase, at any time and from time to time through March 24, 2004, one million shares of LAMP common stock at a purchase price of $0.22 per share and the other of which entitles CRG to purchase that number of shares, if any, of LAMP common stock equal to ten percent (10%) of the total number of shares of LAMP common stock issued or committed to be issued (including shares underlying any securities which are convertible into shares of LAMP common stock but excluding any shares included in the Selling Shareholder table of LAMP'S prospectus dated November 25, 2003 (see www.sec.gov) by LAMP during the ninety (90) day period commencing November 25, 2003. This warrant may be exercised at a price of $0.01 per share at any time but prior to the later to occur of (i) March 24, 2004; or (ii) 30 days after LAMP notifies CRG in writing of the issuance by LAMP of shares which are issuable upon the exercise of this warrant. CRG intends to sell its shares. From November 26 through Janyary 31, 2004, CRG sold approximately three million of such LAMP shares. CRG may sell its shares for less than any target price given in this opinion. CRG's affiliates, officers, directors and employees may also have bought or may buy shares (pursuant to the exercise of warrants or otherwise) discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

CONTACT: Charles T. Tamburello Capital Research Group Inc 954-217-9555